“Autologous T-Cell Vaccines Materials And Methods.“
Application 266/DELNP/2004 published 2006-03-10, filed 2004-02-06
The present invention relates to improved autologous T cell vaccines and methods for their production. The invention is also directed to methods for treating T cell associated diseases such as multiple sclerosis are rheumatoid arthritis using autologous T cell vaccines.
Applicant
Baylor College of Medicine & Opexa Pharmaceuticals Inc
One Baylor Plaza, Houston, Texas 77030, United States of America & 835 Greens Parkway, Suite 150, Houston, Texas 77067, United States of America
Inventor
JINGWU ZHANG
International Info
Classification: A61K 39/00
Publication Number: WO 03/024393
Application Date: 2002-09-12
Priority Information
09/952,532 USA 2001-09-14